Remove 2014 Remove Complication Remove Provider Remove Utilities
article thumbnail

Private Equity Gobbling Up Hospices plus Hospice and Dementia: Melissa Aldridge, Krista Harrison, & Lauren Hunt

GeriPal

Eric: Whenever I hear about for-profit, non-for-profit, the differences between them, mostly everybody turns to, I think, your 2014 paper looking at the differences between for-profit and non-for-profit. Although I saw that hospice was providing a lot of really great quality care for these patients, I also saw a lot of problems.

Family 106
article thumbnail

RCT of PC in ED: Corita Grudzen, Fernanda Bellolio, & Tammie Quest

GeriPal

Most emergency providers wanted to do the right thing for seriously ill patients, but they didnt have the knowledge, skills, or experience to do it. We weren’t randomizing providers or patients. Yeah, that’s a more complicated story. But yeah, it’s complicated. I went into emergency medicine to act.

article thumbnail

Ding Dong is the Skinny Label (Effectively) Dead?

FDA Law

Though the carve-out seems at odds with FDA’s regulations requiring generic drugs to have the “same labeling” as their RLDs, such regulations specifically provide for differences arising from carved-out, patent-protected method of use. Especially now with the utility of the use code minimized. Teva decision changed everything.

IT 52